"Veuillez noter que les règles établies en matière de dépistage et de visites sont différentes pour les établissements de soins de longue durée et pour nos hôpitaux, conformément aux directives du Gouvernement de l’Ontario. Veuillez consulter notre site web pour de plus amples renseignements. ----- Please note that we have different screening and visitation requirements in long-term care and hospitals as per directives from the Ontario government. Please visit our website for more information."

During the past decade, Elisabeth Bruyere Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Elisabeth Bruyere Hospital" #1 sponsor was "Ottawa Hospital Research Institute" with 3 trials, followed by "Bruyere Research Institute" with 2 trials sponsored, "AstraZeneca" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Elisabeth Bruyere Hospital" #1 collaborator was "Bruyere Academic Medical Organization" with 1 trials as a collaborator, "Bruyere Research Institute" with 1 trials as a collaborator, "Canadian Cancer Society (CCS)" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Heart and Stroke Foundation of Canada" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Elisabeth Bruyere Hospital" are "Alzheimer's Disease" (2 trials), "Complex Regional Pain Syndromes" (2 trials), "Stroke" (2 trials), "Alzheimer Disease" (1 trials) and "Depression, Anxiety" (1 trials). Many other conditions were trialed in "Elisabeth Bruyere Hospital" in a lesser frequency.

Most popular intervention types in "Elisabeth Bruyere Hospital" are "Drug" (5 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Control" (1 trials), "Decision aid" (1 trials), "Donanemab" (1 trials) and "Lanabecestat" (1 trials). Other intervention names were less common.

The vast majority of trials in "Elisabeth Bruyere Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Elisabeth Bruyere Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Elisabeth Bruyere Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Elisabeth Bruyere Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".